跳至主要内容
临床试验/EUCTR2019-004600-35-DK
EUCTR2019-004600-35-DK进行中(未招募)1 期

Fat-reduced diet vs. bile acid binder as a treatment for bile acid malabsorption in patients with chronic diarrhoea as a late side effect after cancer treatment in the pelvic region - a randomised, controlled trial.

Department of Hepatology and Gastroenterology, Aarhus University Hospital0 个研究点目标入组 88 人开始时间: 2019年12月4日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients previously treated for cancer in the pelvic region with a se-hcat scanned verified bile acid malabsorption, chronic diarrhoea, and a high fat-intake.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 88
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • If less than 4 bowel movements per day.

研究者

发起方
Department of Hepatology and Gastroenterology, Aarhus University Hospital

相似试验

Fat-reduced diet vs a bile acid binder as a... | 临床试验